1-3 of 3
Weichung Joe Shih
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis

Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, Norio Komatsu, John O. Mascarenhas, Weichung Joe Shih, Oleh Zagrijtschuk, Toshiaki Sato, Kazuya Shimoda, Richard T. Silver, Ruben A. Mesa
Journal: Blood
Blood (2024) 144 (Supplement 1): 3191.1.
https://doi.org/10.1182/blood-2024-200319
Published: 2024
Journal Articles

Paradigm-PV: A Global, Randomized, Multicenter, Two-Arm Phase IV Study to Assess the Efficacy and Safety of Ropeginterferon Alfa-2b in Low- and High-Risk Patients with Polycythemia Vera

Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, Weichung Joe Shih, Waleed Da'na, Tsewang Tashi, Oleh Zagrijtschuk, Robert Geller, Harinder Gill
Journal: Blood
Blood (2024) 144 (Supplement 1): 6626.
https://doi.org/10.1182/blood-2024-199337
Published: 2024
Journal Articles

Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database

Frank Snopek, Ali Seddighzadeh, Megan Flynn, Ling-Yu Cai, Esther Chen, Weichung Joe Shih, Albert Qin, Raymond W Urbanski
Journal: Blood
Blood (2023) 142 (Supplement 1): 6436.
https://doi.org/10.1182/blood-2023-190344
Published: 2023